Dan has 30 years of experience in the pharma/biotech industry, including over 20 years specifically in oncology commercialization, development, and launch. He joins RayzeBio from Mirati Therapeutics, where he was the Vice President of Worldwide Commercial Portfolio Planning, responsible for strategic input into the Mirati pipeline and the commercial lead for their clinical development plan. […] The post Dan Szeliga appeared first on RayzeBio .